Basics Y-mAbs Therapeutics, Inc. IPO Date: September 17, 2018 Sector: Healthcare Industry: Biotech Market Cap: $391.22M Activated in VL: True Average Daily Range Avg Daily Range: $0.59 | 3.24% Avg Daily Range (30 D): $0.02 | 0.17% Avg Daily Range (90 D): $0.09 | 1.98% Institutional Daily Volume Avg Daily Volume: .27M Avg Daily Volume (30 D): .06M Avg Daily Volume (90 D): .58M Trade Size Avg Trade Size (Sh.): 83 Avg Trade Size (Sh.) (30 D): 212 Avg Trade Size (Sh.) (90 D): 256 Institutional Trades Total Inst.Trades: 1,174 Avg Inst. Trade: $1.43M Avg Inst. Trade (30 D): $.97M Avg Inst. Trade (90 D): $2.01M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.43M Avg Closing Trade (30 D): $1.23M Avg Closing Trade (90 D): $.83M Avg Closing Volume: 65.51K     News Sep 16, 2025 @ 12:41 PM SERB Pharmaceuticals Completes Acquisition of Y-mA... Source: Globe Newswire Aug 26, 2025 @ 7:56 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith Aug 8, 2025 @ 11:37 AM Y-mAbs (YMAB) Q2 Revenue Falls 14% Source: Jesterai Aug 7, 2025 @ 10:44 PM $HAREHOLDER ALERT: The M&A Class Action Firm Annou... Source: Juan Monteverde Aug 5, 2025 @ 6:46 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.5 $-.07 $-.12 Diluted EPS $-.5 $-.07 $-.12 Revenue $ 85.39M $ 19.53M $ 20.9M Gross Profit $ 69.83M $ 16.86M $ 17.9M Net Income / Loss $ -22.22M $ -3.24M $ -5.2M Operating Income / Loss $ -26.65M $ -5.6M $ -6.54M Cost of Revenue $ 15.55M $ 2.66M $ 3M Net Cash Flow $ -4.94M $ 1.98M $ -6.92M PE Ratio